首页 | 本学科首页   官方微博 | 高级检索  
     

临床路径对冠心病并2型糖尿病患者实施干预的研究
引用本文:翟振道,韩玉亭,苏金平,夏美娜,张华敏. 临床路径对冠心病并2型糖尿病患者实施干预的研究[J]. 中国实用医药, 2009, 4(34): 14-15
作者姓名:翟振道  韩玉亭  苏金平  夏美娜  张华敏
作者单位:山东省昌邑市人民医院,261300
摘    要:目的应用临床路径对冠心病合并2型糖尿病患者实施干预的效果研究。方法选择我院60例冠心病合并2型糖尿病患者分为两组,观察组给予临床路径干预,对照组给予常规治疗。评测两组患者心功能改善情况和血糖控制情况。结果观察组心功能改善、空腹血糖、餐后血糖和糖化血红蛋白都优于对照组。结论临床路径改善了患者的心功能和血糖控制情况,满足了患者的健康需求,增进了医患关系。

关 键 词:冠状动脉疾病,2型糖尿病,临床路径  干预性研究

A study on effect of clinical path applied for coronary disease with type2 diabetes mellitus
Affiliation:ZHAI Zhen-dao, HAN Yu-ting, SUN Jin-ping, et al. (The People' s Hospital of Changyi city in ShanDong Province, ShanDong Chan Yi 261300, China)
Abstract:Objective To explore the effect of clinical path for coronary disease with type2 diabetes mellitus. Methods 60 patients of coronary disease with type2 diabetes mellitus were divided into two groups. The patients in the experimental group received clinical path service. Then, the patients' ehanges of heart function and quality in evaluating diabetes control was compared between experimental group and control group. Resuits The patients' heart function, FBS, PBS , and HbA1C in experimental group were better than that control group . Conclusion Clinical path is a convenient and economic means ,which not only can improve changes of heart function and quality in evaluating diabetes control, but also can facilitate relationship between the doctors and the patients, and meet the patients' health needs.
Keywords:Coronary disease  Type2 diabetes mellitus  Clinical Path  Intervention study
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号